SCHEDULE OF WARRANTS ACTIVITIES (Details) - Warrant [Member] - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Warrants, Outstanding, Beginning Balance | 1,733,509,804 | 1,101,509,804 |
| Weighted Average Exercise Price, Outstanding, Beginning Balance | $ 0.0206 | $ 0.03257 |
| Warrants, Granted | 895,000,000 | |
| Weighted Average Exercise Price, Outstanding, Granted | $ 0.0000075 | |
| Warrants, Exercised | ||
| Weighted Average Exercise Price, Outstanding, Exercised | ||
| Warrants, Forfeited/Exchanged | (75,000,000) | (263,000,000) |
| Weighted Average Exercise Price, Outstanding, Forfeited/Exchanged | ||
| Warrants, Expired | (80,509,804) | |
| Weighted Average Exercise Price, Outstanding, Expired | ||
| Warrants, Outstanding, Ending Balance | 1,578,000,000 | 1,733,509,804 |
| Weighted Average Exercise Price, Outstanding, Ending Balance | $ 0.01908 | $ 0.0206 |
| Warrants, Intrinsic Value | $ 102,250 | |
| Warrants, Weighted Average Remaining Contractual Life | 2 years 4 months 6 days | 3 years 2 months 8 days |
| X | ||||||||||
- Definition Warrants intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price outstanding exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price outstanding expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price outstanding forfeited. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price outstanding granted. No definition available.
|
| X | ||||||||||
- Definition Warrants weighted average remaining contractual life. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|